Concepedia

Sara Khattab

SK

3

Publications

127

Citations

3

H-Index

2024

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Massachusetts General Hospital

Sara Khattab is an author at Dana-Farber Cancer Institute specializing in autoimmunity, immune dysregulation, and tumor immunity.

ORCID

Top concepts

Publications per year

2024–2025

3

Publications

3

Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study

Guihong Wan, Wenxin Chen, Sara Khattab et al. · The Lancet Oncology · 2024 · 67 citations · Full text

, , +13

TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial

Richard G. Everson, Willy Hugo, Lu Sun et al. · Nature Communications · 2024 · 50 citations · Full text

Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse events

Sara Khattab, Guihong Wan, Suzanne Xu et al. · Journal for ImmunoTherapy of Cancer · 2025 · 10 citations · Full text

Rows per page

1–3 of 3